Christopher Baldwin

Corporate Officer/Principal en BCAL DIAGNOSTICS LIMITED .

Health Services

Consumer Services

Health Technology

Perfil

Christopher Baldwin is currently Chief Commercial Officer at BCAL Diagnostics Ltd. Formerly, Dr. Baldwin was Chief Commercial Officer & Deputy CEO at Exopharm Ltd. from 2021 to 2022 and Executive Director at New York Blood Center, Inc. Education includes a doctorate from Trinity College.

Cargos activos de Christopher Baldwin

Empresas	Cargo	Inicio
BCAL DIAGNOSTICS LIMITED	Corporate Officer/Principal	-

Todos los cargos activos de Christopher Baldwin

Antiguos cargos conocidos de Christopher Baldwin.

Empresas	Cargo	Fin
EXOPHARM	Corporate Officer/Principal	01/02/2022
New York Blood Center, Inc. New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Christopher Baldwin.

Formación de Christopher Baldwin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher Baldwin.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
New York Blood Center, Inc. New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization	Health Services
Trinity College Trinity College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BCAL Diagnostics Ltd. BCAL Diagnostics Ltd. Medical/Nursing ServicesHealth Services Engages in medical research and testing services	Health Services
Exopharm Ltd. Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent	Health Technology